Loading...
| A02393 | Pages: NA | Aug 2021 | 4773 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Glucosamine Supplements Market
Request Now !Glucosamine is an amino acid found naturally in the cartilage of the joints. It is a precursor in the biochemical synthesis of glycosylated proteins and lipids. The amino acid is produced commercially by the hydrolysis of crustacean exoskeletons and is used in medical conditions such as osteoarthritis and arthritis. In addition, glucosamine supplements possess anti-inflammatory and anti-aging properties as well as they also help improve digestion, gut health, and treat inflammatory bowel disease.
Hence, these supplements are majorly taken by people with bone and joint pain as well as people suffering from temporo-manibular joint (TMJ) disorder. Furthermore, glucosamine supplements are also used in cosmetic products as it aids in the formation of connective tissue and promotes exfoliation (removal of dead skin) and hydration.
The growth in geriatric population and disorders related to bone and joints such as osteoarthritis and arthritis majorly drive the growth of this market. In addition, the increase in need for glucosamine supplements for promoting healthy growth of skin and hair also fuels the market growth. Further, less awareness among people regarding the benefits of glucosamine supplements as well as presence of many substitutes such as omega 3 fatty acids, collagens, and fish oils coupled with herbal ingredients is expected to restrict the growth of glucosamine supplements market.
The global glucosamine supplements market is segmented based on applications, dosage form, and region. Based on application, the market is divided on the basis of osteoarthritis, nutritional dietary supplements, and others. Based on dosage form, it is classified into pill, capsules, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Paul Marienfeld, Hecht Assistant, Comdek Industrial, Cypress Diagnostics, HemoCue, KPG Products, Danaher Corporation, GE Healthcare, Nava medic ASA, and Nutraceutix Inc. is also provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 GLOBAL GLUCOSAMINE SUPPLEMENTS MARKET, BY APPLICATIONS
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. OSTEOARTHRITIS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. NUTRITIONAL DIETARY SUPPLEMENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 GLOBAL GLUCOSAMINE SUPPLEMENTS MARKET, BY DOSAGE FORM
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. PILLS
5.2.1. Market size and forecast
5.3. CAPSULES
5.3.1. Market size and forecast
5.4. OTHERS
5.4.1. Market size and forecast
CHAPTER 6 GLOBAL GLUCOSAMINE SUPPLEMENTS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Glucosamine Supplements Market by Applications
6.2.5. North America Glucosamine Supplements Market by Dosage Form
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.3.4. Europe Glucosamine Supplements Market by Applications
6.3.5. Europe Glucosamine Supplements Market by Dosage Form
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Glucosamine Supplements Market by Applications
6.4.5. Asia-Pacific Glucosamine Supplements Market by Dosage Form
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Glucosamine Supplements Market by Applications
6.5.5. LAMEA Glucosamine Supplements Market by Dosage From
CHAPTER 7 COMPANY PROFILES
7.1. PAUL MARIENFELD
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. HECHT ASSISTANT
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. COMDEK INDUSTRIAL
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. CYPRESS DIAGNOSTICS
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. HEMOCUE
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. KPG PRODUCTS
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. DANAHER CORPORATION
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. GE HEALTHCARE
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. NAVA MEDIC ASA
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. NUTRACEUTIX INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
